DRUG/AGENT TOXICITY BY TISSUE/ORGAN
Clinical trials for DRUG/AGENT TOXICITY BY TISSUE/ORGAN explained in plain language.
Never miss a new study
Get alerted when new DRUG/AGENT TOXICITY BY TISSUE/ORGAN trials appear
Sign up with your email to follow new studies for DRUG/AGENT TOXICITY BY TISSUE/ORGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug cocktail shows promise for kids with resistant neuroblastoma
Disease control CompletedThis early-phase study tested a combination of three oral drugs (irinotecan, temozolomide, and cefixime) in 30 children whose high-risk neuroblastoma had come back or not responded to standard treatment. The goal was to find the safest dose of irinotecan when given with the other…
Matched conditions: DRUG/AGENT TOXICITY BY TISSUE/ORGAN
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Major study finds safer way to give key leukemia drug to kids
Disease control CompletedThis study looked at 800 children with acute lymphoblastic leukemia to compare two forms of the drug asparaginase: a pegylated version given through a vein and a standard version given as a shot. The goal was to see which caused fewer serious side effects like allergic reactions,…
Matched conditions: DRUG/AGENT TOXICITY BY TISSUE/ORGAN
Phase: PHASE3 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC